XML 24 R13.htm IDEA: XBRL DOCUMENT v3.25.1
Stockholders’ Equity
 9 Months Ended
Mar. 31, 2025
Equity [Abstract]  
Stockholders’ Equity

 

7. Stockholders’ Equity

  

Restricted Stock Units (“RSUs”)

 

The following table presents a summary of activity with respect to our RSUs:

          
   Number of
Shares		   Weighted-Average Grant Date
Fair Value
per Share		 
   (In thousands)      
Balance of RSUs outstanding at June 30, 2024   1,881   $4.89 
Granted   1,413    3.37 
Forfeited   (391)   4.19 
Vested   (726)   5.05 
Balance of RSUs outstanding at March 31, 2025   2,177   $3.97 

 

Performance Stock Units (“PSUs”)

 

The following table presents a summary of activity with respect to our PSUs:

     
   Number of Shares 
   (In thousands) 
Balance of PSUs outstanding at June 30, 2024   1,669 
Granted   583 
Forfeited   (588)
Vested   (669)
Balance of PSUs outstanding at March 31, 2025   995 

 

Stock Options

 

The following table presents a summary of activity with respect to our stock options:

          
   Number of Shares   Weighted-Average Exercise Price
per Share		 
   (In thousands)      
Balance of options outstanding at June 30, 2024   567   $4.13 
Forfeited   (15)   5.46 
Expired   (14)   2.19 
Exercised   (230)   3.36 
Balance of options outstanding at March 31, 2025   308   $4.74 

 

Employee Stock Purchase Plan (“ESPP”)

 

The following table presents a summary of activity under our ESPP:

     
   Number of 
   Shares 
   (In thousands) 
Shares available for issuance at June 30, 2024  $181 
Shares issued   (84)
Shares available for issuance at March 31, 2025  $97 

 

Share-Based Compensation Expense

 

The following table presents a summary of share-based compensation expense included in each applicable functional line item on our accompanying unaudited condensed consolidated statements of operations:

                    
   Three Months Ended   Nine Months Ended 
   March 31,   March 31, 
   2025   2024   2025   2024 
   (In thousands) 
Cost of revenue  $34   $66   $146   $171 
Selling, general and administrative   1,159    1,337    3,329    4,238 
Research and development   324    469    1,155    1,381 
Total share-based compensation expense  $1,517   $1,872   $4,630   $5,790 

 

The following table presents the remaining unrecognized share-based compensation expense related to our outstanding share-based awards as of March 31, 2025:

          
   Remaining Unrecognized Compensation Expense   Remaining Weighted-Average Years To Recognize 
   (In thousands)      
Stock options  $106    1.8 
RSUs   7,297    2.2 
PSUs   2,694    1.9 
Stock purchase rights under ESPP   19    0.1 
   $10,116      

  

If there are any modifications or cancellations of the underlying unvested share-based awards, we may be required to accelerate, increase or cancel remaining unearned share-based compensation expense. Future share-based compensation expense and unearned share-based compensation expense will increase to the extent that we grant additional share-based awards.